Whitehawk Therapeutics, Inc. (WHWK) — Financial Flexibility Index
Whitehawk Therapeutics, Inc. (WHWK) has a Financial Flexibility Index of -1.56x as of September 2025. Free cash flow of $-15.38 Million (operating CF $-15.38 Million minus capex $0.00) represents -2% of total liabilities ($9.85 Million). Also explore net asset growth rate of Whitehawk Therapeutics, Inc. to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Whitehawk Therapeutics, Inc. Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Whitehawk Therapeutics, Inc. across 6 annual periods. Check Whitehawk Therapeutics, Inc. (WHWK) asset resilience to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Whitehawk Therapeutics, Inc. (2019–2024)
Year-by-year free cash flow to debt coverage for Whitehawk Therapeutics, Inc.. For the full company profile including market capitalisation, see Whitehawk Therapeutics, Inc. (WHWK) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.25x | $-57.90 Million | $-59.55 Million | $17.84 Million | ▼ -58.7% |
| 2023 | -2.05x | $-55.69 Million | $-59.66 Million | $27.23 Million | ▼ -7.5% |
| 2022 | -1.90x | $-49.20 Million | $-49.64 Million | $25.86 Million | ▼ -82.8% |
| 2021 | -1.04x | $-22.38 Million | $-22.42 Million | $21.50 Million | ▼ -156.1% |
| 2020 | -0.41x | $-12.70 Million | $-12.70 Million | $31.26 Million | ▼ -38.6% |
| 2019 | -0.29x | $-7.55 Million | $-7.58 Million | $25.75 Million | — |